Renaissance Technologies’s Edesa Biotech EDSA Stock Holding History
Bought
Maintained
Sold
Other funds holding EDSA
RCMNY
SCM
VCIM
NCM
DS
DP
Renaissance Technologies's EDSA Position: Q4 2025 in Review
Renaissance Technologies sold out of Edesa Biotech (EDSA) in Q4 2025, closing a stake of 25,000 shares — an estimated $61.8K sold.
Renaissance Technologies first reported a position in EDSA in Q4 2017 and held it in 13 quarters. The position peaked at $315K in Q4 2020. 22 funds tracked by Wall St. Rank hold EDSA as of Q4 2025.
- Renaissance Technologies reported no remaining Edesa Biotech position as of Q4 2025 after selling out during the quarter.
- Renaissance Technologies sold 25,000 Edesa Biotech shares in Q4 2025, an estimated $61.8K.
- Renaissance Technologies first reported a position in Edesa Biotech in Q4 2017 and held it in 13 quarters.
- Renaissance Technologies's Edesa Biotech position peaked at $315K in Q4 2020.
- 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.